Barely Significant
← all phrases

“showed a trend”

53,323 sentences · 53,323 papers · 65,371 search hits before verification

In the literature

73 Interestingly, 7 R/R patients received the triplet ENA+AZA+Ven and showed a trend toward a better mOS than those treated with ENA+AZA. 73 Preliminary results of a phase Ib/II clinical trial (Enaven-AML trial) explored enasidenib in combination with VEN in a group of AML patients previously treated with at least two lines of treatment and mostly with relapsing or refractory disease. 74 A CR rate of 55% was observed, and all responders remained in remission during the study. 74 Since IDH mutations induced inhibition of the TET2 enzyme, it seemed interesting to explore the effect of VEN-based therapies in TET2 -mutated AMLs.
1 Indeed, the PARAGON-HF study recently showed a trend towards better clinical outcome in chronic renal failure patients treated with sacubitril/valsartan than valsartan itself, especially in the lower end of the EF spectrum, in women, in patients recently hospitalized for heart failure and in those with high sensitivity troponin values at baseline.
During the regeneration process of skeletal muscle injury, the expressions of TNFα , IL6 , cyclin B ( CCNB) , cyclin D (CCND) and MyoD all showed a trend of increasing first and then decreasing, while the expression of MyoG showed a trend of first decreasing, then increasing and finally decreasing ( Figure 1 B–D).
Patients with mitochondrial disease had a higher frequency of mtDNA pathogenic mutations (62%) than nDNA (38%), and showed a trend where mtDNA mutations were prevalent in patients older than 2, and nDNA mutations were more frequently found in the infancy-onset disease group. 24 mtDNA mutations were highly associated with endocrinopathies and diabetes mellitus compared with nDNA mutations, suggesting a possible association of mtDNA mutations with age-related, non-mitochondrial diseases.